$955 Million is the total value of Rhenman & Partners Asset Management AB's 90 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIIB | New | BIOGEN INC | $9,292,000 | – | 32,782 | +100.0% | 0.97% | – |
| PODD | New | INSULET CORP | $7,505,000 | – | 29,000 | +100.0% | 0.79% | – |
| NVST | New | ENVISTA HOLDINGS CORPORATION | $4,747,000 | – | 143,800 | +100.0% | 0.50% | – |
| KRTX | New | KARUNA THERAPEUTICS INC | $4,387,000 | – | 20,000 | +100.0% | 0.46% | – |
| WST | New | WEST PHARMACEUTICAL SVSC INC | $3,912,000 | – | 17,000 | +100.0% | 0.41% | – |
| NTRA | New | NATERA INC | $3,757,000 | – | 80,000 | +100.0% | 0.39% | – |
| ALHC | New | ALIGNMENT HEALTHCARE INC | $3,640,000 | – | 274,950 | +100.0% | 0.38% | – |
| TXG | New | 10X GENOMICS INC | $2,039,000 | – | 75,000 | +100.0% | 0.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.